PIQ proteomics international laboratories ltd

Ann: PromarkerD US market update, page-3

  1. 15,731 Posts.
    lightbulb Created with Sketch. 1793
    PromarkerD US Market Update     Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners New immunoassay technology platform to accelerate PromarkerD rollout in US Clinical samples for first phase of CDx collaborative study received from Janssen Research & Development, LLC Key Opinion Leader (KOL) engagement to drive US demand for PromarkerD
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $49.05M
Open High Low Value Volume
30.5¢ 30.5¢ 29.0¢ $48.86K 162.9K

Buyers (Bids)

No. Vol. Price($)
2 9700 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 5000 1
View Market Depth
Last trade - 10.42am 27/06/2025 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.